GlassScriptPhysician profile
Anthony G Avitabile
NPI 1518942341
$13,154.44
in general payments reported to CMS, 2019-2025
56 companies · $1,962 in 2025
The $1,962 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $1,685 · 2021: $2,327 · 2022: $2,228 · 2023: $2,333 · 2024: $2,397 · 2025: $1,962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,683 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,683.17 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,618.06 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $1,793.41 | 2019-2025 | Vraylar, Creon, Ubrelvy |
| Bayer Healthcare Pharmaceuticals INC. | $1,213.40 | 2021-2025 | |
| Lilly USA, LLC | $952.80 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Otsuka America Pharmaceutical, INC. | $688.02 | 2019-2025 | Rexulti |
| Pfizer INC. | $676.61 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $540.77 | 2019-2025 | Airsupra, Farxiga, Andexxa |
| Amgen INC. | $405.18 | 2019-2025 | Otezla, Repatha, Krystexxa |
| Supernus Pharmaceuticals, INC. | $325.28 | 2022-2025 | Qelbree, Qelbree |
| Biohaven Pharmaceuticals, INC. | $260.83 | 2020-2021 | |
| Lundbeck LLC | $259.95 | 2022-2025 | Rexulti |
| Axsome Therapeutics, INC. | $250.98 | 2025 | Auvelity, Sunosi |
| Glaxosmithkline, LLC. | $236.69 | 2020-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Corcept Therapeutics | $200.32 | 2021-2025 | Korlym |
| Corium, LLC | $196.62 | 2023-2025 | Azstarys |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $188.74 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $173.41 | 2019-2023 | Trintellix |
| Intra-Sana Laboratories | $172.74 | 2024-2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| E.R. Squibb & Sons, L.L.C. | $114.48 | 2019-2023 | Eliquis |
| Amarin Pharma, INC. | $105.51 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $104.39 | 2020-2023 | Seglentis |
| Neos Therapeutics, LP | $104.20 | 2020-2023 | Adzenys Xr-Odt |
| Exact Sciences Corporation | $103.25 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Arbor Pharmaceuticals, INC. | $87.84 | 2020-2022 | |
| Vanda Pharmaceuticals INC. | $87.48 | 2024 | Fanapt |
| Janssen Pharmaceuticals, INC | $86.54 | 2024 | Spravato |
| Abbott Laboratories | $86.37 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.95 | 2022-2025 | Xifaxan |
| Merck Sharp & Dohme LLC | $82.57 | 2020-2025 | Gardasil 9, Capvaxive, Varivax |
| Allergan, INC. | $82.00 | 2020 | |
| Ironshore Pharmaceuticals INC. | $76.23 | 2019-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $69.78 | 2022 | |
| Seqirus USA INC | $69.46 | 2023-2024 | Fluad Quadrivalent, Flucelvax Quadrivalent, Flucelvax |
| Esperion Therapeutics, INC. | $66.36 | 2021-2025 | Nexletol |
| Medtronic, INC. | $49.02 | 2024-2025 | Kyphon Express II Kyphopak Tray, Minimed 780g |
| Jazz Pharmaceuticals INC. | $45.34 | 2020-2021 | |
| Astellas Pharma US INC | $44.92 | 2024 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.85 | 2020-2025 | Jardiance |
| Daiichi Sankyo INC. | $39.37 | 2021 | |
| Azurity Pharmaceuticals, INC. | $37.84 | 2023 | Edarbi, Edarbyclor |
| Xeris Pharmaceuticals, INC. | $36.99 | 2023-2024 | Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $36.01 | 2021 | |
| Novartis Pharmaceuticals Corporation | $32.01 | 2019-2020 | |
| Horizon Therapeutics Plc | $25.18 | 2022-2023 | Krystexxa |
| Almatica Pharma LLC | $22.28 | 2025 | Loreev Xr |
| Inspire Medical Systems, INC. | $21.82 | 2025 | Inspire |
| Insulet Corporation | $21.05 | 2025 | Omnipod |
| Teva Pharmaceuticals USA, INC. | $19.78 | 2023 | Austedo Xr |
| Philips North America LLC | $18.88 | 2024 | (Ck7) Extended Holter |
| Dexcom, INC. | $17.03 | 2024 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $16.17 | 2024 | Voquezna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.33 | 2022 | |
| Idorsia Pharmaceuticals US INC | $13.86 | 2023 | Quviviq |
| Linus Health, INC. | $12.59 | 2024 | Core Cognitive Evaluation |
| Genentech USA, INC. | $12.54 | 2022 | |
| Medtronic Minimed, INC. | $11.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Avitabile listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.